D236 Comprehensive Medical Conditions Outline

D236 Comprehensive Medical Conditions Outline

D236 Comprehensive Medical Conditions Outline

Name

Western Governors University

D236 Pathophysiology

Prof. Name

Date

Rhabdomyolysis

Rhabdomyolysis is a pathological condition involving the destruction of skeletal muscle fibers. This breakdown results in the release of intracellular components such as myoglobin into the bloodstream. Myoglobin, when released in excessive amounts, poses a significant challenge to kidney function as the kidneys filter it through the nephrons. The toxic effect of myoglobin on renal tubular cells can cause acute tubular necrosis, leading to acute kidney injury (AKI) (Huerta-Alardín, Varon, & Marik, 2005).

What are the clinical signs of rhabdomyolysis?
Patients commonly present with a triad of symptoms: muscle pain (myalgia), generalized weakness, and dark-colored urine due to myoglobinuria. It is important to highlight that over half of patients may not experience muscle pain or weakness, with the earliest sign sometimes being discolored urine, often described as tea-colored (Torres et al., 2021).

How is rhabdomyolysis diagnosed?
The key laboratory marker for diagnosis is a markedly elevated serum creatine kinase (CK) level, with values exceeding five times the upper normal limit strongly supporting the diagnosis. Differentiating elevated CK caused by skeletal muscle damage from cardiac or neurological origins is critical (Melli, Chaudhry, & Cornblath, 2005).

Clinical FindingDescription
MyalgiaDiffuse muscle soreness and pain
WeaknessReduced muscle strength and fatigue
MyoglobinuriaDark (tea or cola) colored urine due to myoglobin excretion
Elevated CKSerum CK elevated >5 times upper normal limit indicating muscle injury
ComplicationAcute kidney injury caused by myoglobin-induced nephrotoxicity

Phagocytosis

What is phagocytosis?
Phagocytosis is a vital immune defense mechanism whereby specialized cells such as neutrophils and macrophages engulf and eliminate invading pathogens or foreign particles. This complex process includes several steps: recognition of the target, attachment, engulfment, and intracellular digestion. The cell membrane extends pseudopods to surround the target, forming a phagosome. Lysosomes then fuse with the phagosome, releasing enzymes and reactive oxygen species to degrade the engulfed material (Underhill & Goodridge, 2012).

StageProcess Description
Recognition & AttachmentLeukocytes detect and bind foreign material
EngulfmentPseudopods surround and internalize the target
Phagosome FormationFormation of an intracellular vesicle enclosing the target
DigestionLysosomal enzymes degrade or kill the ingested material

Ovarian Cancer

Ovarian cancer is notorious for its silent and asymptomatic early stages, emphasizing the importance of biomarker testing for early detection. Two key biomarkers are primarily used: CA-125 and Human Epididymis Protein 4 (HE4). CA-125, a glycoprotein, is often elevated in epithelial ovarian cancers but can also increase in benign conditions. HE4 offers greater specificity for ovarian malignancies. The combination of both markers in the Risk of Ovarian Malignancy Algorithm (ROMA) enhances diagnostic accuracy (Moore et al., 2008).

BiomarkerClinical Use
CA-125Screening and monitoring ovarian cancer progression
HE4Provides higher specificity in detecting ovarian cancer
ROMA IndexAlgorithm combining CA-125 and HE4 to estimate malignancy risk

Hypospadias

Hypospadias is a congenital anomaly in males where the urethral opening is located on the underside (ventral surface) of the penis rather than at the tip. The severity varies from mild subcoronal placement to severe perineal forms. This condition can interfere with urination and fertility due to abnormal semen deposition. Surgical correction in infancy is the preferred treatment to restore function and appearance (Carmichael et al., 2013).


Hypogonadism and Cryptorchidism

What are hypogonadism and cryptorchidism?
Hypogonadism is defined as inadequate production of testosterone or sperm by the testes. Cryptorchidism refers to the failure of one or both testes to descend into the scrotum before birth. These are common congenital disorders affecting newborn males.

Cryptorchidism is concerning because it increases the risk of infertility and testicular cancer later in life. Early surgical intervention, typically orchiopexy before the age of two, is recommended to reduce these risks (Kolon et al., 2014).

ConditionDescriptionComplications
HypogonadismLow testosterone or impaired sperm productionInfertility, delayed puberty
CryptorchidismUndescended testesInfertility, increased risk of testicular cancer

Appendicitis

Appendicitis is an acute inflammation of the appendix usually caused by obstruction due to fecaliths, lymphoid hyperplasia, or foreign bodies. This condition is a surgical emergency to prevent complications such as perforation or peritonitis.

What are the common symptoms of appendicitis?
Patients often initially experience peri-umbilical pain that later localizes to the right lower quadrant (RLQ), especially at McBurney’s point. Other symptoms include nausea, vomiting, anorexia, mild fever, and chills. Activities like movement, coughing, or deep breathing tend to worsen the pain (Addiss, Shaffer, Fowler, & Tauxe, 1990).

SymptomDescription
Abdominal PainStarts peri-umbilical, migrates to RLQ
Nausea & VomitingUsually follows abdominal pain
Fever & ChillsMild to moderate, indicating inflammation
AnorexiaLoss of appetite
Constipation/DiarrheaSometimes present with abdominal bloating

Which physical signs assist in diagnosing appendicitis?

SignProcedurePositive Finding
Psoas SignPatient flexes right thigh against resistanceRLQ pain due to psoas muscle irritation
Rovsing’s SignPalpation of left lower quadrantRLQ pain indicating appendiceal inflammation
Rebound TendernessRapid release after deep abdominal palpationSharp pain indicating peritoneal irritation
Obturator SignFlexion and rotation of right hipRLQ pain from obturator muscle irritation
GuardingInvoluntary abdominal muscle contractionSuggests peritoneal irritation

Untreated appendicitis can lead to life-threatening complications such as perforation and peritonitis. The primary treatment is surgical appendectomy, often preceded by antibiotic therapy.


Peptic Ulcer Disease

Peptic ulcer disease (PUD) involves the formation of open sores in the stomach lining or the proximal duodenum. This occurs due to an imbalance between aggressive factors like gastric acid and pepsin, and protective mechanisms such as mucus and bicarbonate secretion.

What causes PUD?
The most common cause is Helicobacter pylori infection, which damages the mucosa and induces inflammation. Chronic use of NSAIDs also contributes by reducing prostaglandin synthesis, thus weakening mucosal defenses. Additional risk factors include smoking, excessive alcohol use, stress, and genetic predisposition (Sung, Kuipers, & El-Serag, 2009).

SymptomDescription
Epigastric PainBurning sensation worsened by fasting or night
Nausea and VomitingAccompany ulcer symptoms
Hematemesis/MelenaVomiting blood or black stools indicating bleeding
Weight LossDue to chronic symptoms and loss of appetite

Ulcerative Colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by continuous mucosal inflammation beginning in the rectum and extending proximally in the colon. Unlike Crohn’s disease, UC affects only the mucosal layer.

The inflammation leads to ulceration, bleeding, and absorption issues. Patients commonly suffer from bloody diarrhea, abdominal cramps, and urgency. The disease often has a relapsing-remitting pattern, with systemic symptoms such as fever and weight loss during flare-ups (Ordás et al., 2012).

Clinical FeatureTypical Presentation
Bloody DiarrheaFrequent stools with blood and mucus
Abdominal PainCramping, often in lower abdomen
TenesmusUrgency and sensation of incomplete evacuation
Extraintestinal ManifestationsArthritis, skin lesions, eye inflammation

Asthma

Asthma is a chronic inflammatory disease of the airways, marked by reversible airflow obstruction and bronchial hyperresponsiveness, triggered by allergens or irritants.

Common symptoms include episodic wheezing, shortness of breath, chest tightness, and coughing, particularly at night or early morning. The underlying pathology involves airway inflammation, excessive mucus production, and bronchospasm (GINA, 2023).

SymptomCharacteristic Features
WheezingHigh-pitched expiratory sounds
DyspneaEpisodic difficulty in breathing
CoughPersistent, may be dry or productive
Chest TightnessSensation of constriction or pressure

Bronchiectasis

Bronchiectasis is a chronic lung condition characterized by permanent dilation and destruction of bronchial walls. This leads to impaired clearance of mucus and recurrent infections.

It can result from repeated infections, cystic fibrosis, immunodeficiencies, or congenital abnormalities. Patients often have chronic productive cough, excessive purulent sputum, hemoptysis, and frequent respiratory infections (King, 2009).

SymptomClinical Relevance
Chronic CoughPersistent productive cough
Sputum ProductionLarge volumes of purulent sputum
HemoptysisCoughing blood due to bronchial wall damage
Recurrent InfectionsFrequent pneumonia or bronchitis episodes

Chronic Bronchitis

Chronic bronchitis, a subtype of chronic obstructive pulmonary disease (COPD), involves chronic bronchial inflammation with excessive mucus secretion and productive cough lasting at least three months for two consecutive years.

Patients usually report daily productive cough, exertional dyspnea, and frequent respiratory infections. Smoking is the predominant cause, contributing to airway inflammation and mucus gland enlargement (GOLD, 2024).

FeatureDescription
Chronic CoughProductive cough lasting >3 months
DyspneaShortness of breath on exertion
Frequent InfectionsExacerbations triggered by infections
CyanosisLate sign of hypoxemia, called “blue bloater”

Emphysema

Emphysema is another COPD subtype, characterized by destruction of alveolar walls and enlargement of distal air spaces, impairing gas exchange and reducing elastic recoil.

Smoking is the primary cause, with alpha-1 antitrypsin deficiency as a genetic risk factor. Symptoms include progressive dyspnea, minimal cough, and a barrel-shaped chest. Patients are often described as “pink puffers” due to relatively preserved oxygenation until late stages (Celli & MacNee, 2004).

CharacteristicDescription
DyspneaProgressive shortness of breath
Minimal CoughLess frequent than chronic bronchitis
Barrel ChestIncreased anteroposterior chest diameter
Pursed-Lip BreathingHelps improve ventilation

Asthma versus COPD

FeatureAsthmaCOPD
Age of OnsetUsually childhood or early adulthoodTypically middle-aged or older adults
ReversibilityMostly reversible airway obstructionPartially reversible or irreversible obstruction
Inflammation TypeEosinophilic, allergicNeutrophilic, smoking-related
SymptomsEpisodic wheezing and coughChronic cough, sputum, progressive dyspnea
TriggersAllergens, exercise, cold airSmoking, pollution, infections

References

Addiss, D. G., Shaffer, N., Fowler, B. S., & Tauxe, R. V. (1990). The epidemiology of appendicitis and appendectomy in the United States. American Journal of Epidemiology, 132(5), 910–925.

Carmichael, S. L., Shaw, G. M., Laurent, C., Croughan, M. S., & Olney, R. S. (2013). Maternal reproductive and demographic characteristics as risk factors for hypospadias. Paediatric and Perinatal Epidemiology, 27(4), 353–359.

Celli, B. R., & MacNee, W. (2004). Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. European Respiratory Journal, 23(6), 932–946.

Global Initiative for Asthma (GINA). (2023). Global strategy for asthma management and prevention. Retrieved from https://ginasthma.org

Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2024). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Retrieved from https://goldcopd.org

Huerta-Alardín, A. L., Varon, J., & Marik, P. E. (2005). Bench-to-bedside review: Rhabdomyolysis — an overview for clinicians. Critical Care, 9(2), 158–169.

King, P. T. (2009). The pathophysiology of bronchiectasis. International Journal of Chronic Obstructive Pulmonary Disease, 4, 411–419.

Kolon, T. F., Herndon, C. D., Baker, L. A., Baskin, L. S., Baxter, C. G., Cheng, E. Y., … & Barthold, J. S. (2014). Evaluation and treatment of cryptorchidism: AUA guideline. The Journal of Urology, 192(2), 337–345.

Melli, G., Chaudhry, V., & Cornblath, D. R. (2005). Rhabdomyolysis: An evaluation of 475 hospitalized patients. Medicine, 84(6), 377–385.

Moore, R. G., Brown, A. K., Miller, M. C., Skates, S., Allard, W. J., Verch, T., … & Bast, R. C. (2008). The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecologic Oncology, 108(2), 402–408.

Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C., & Sandborn, W. J. (2012). Ulcerative colitis. The Lancet, 380(9853), 1606–1619.

Sung, J. J., Kuipers, E. J., & El-Serag, H. B. (2009). Systematic review: the global incidence and prevalence of peptic ulcer disease. Alimentary Pharmacology & Therapeutics, 29(9), 938–946.

Torres, P. A., Helmstetter, J. A., Kaye, A. M., & Kaye, A. D. (2021). Rhabdomyolysis: Pathogenesis, diagnosis, and treatment. Ochsner Journal, 21(1), 58–69.

Underhill, D. M., & Goodridge, H. S. (2012). Information processing during phagocytosis. Nature Reviews Immunology, 12(7), 492–502.